Form Type: 4

SEC EDGAR Link
Accession Number:0001683168-22-002000
Date:2022-03-24
Issuer: XENETIC BIOSCIENCES, INC. (XBIO)
Original Submission Date:

Reporting Person:

EISENBERG JEFFREY F
40 SPEEN STREET, SUITE 102
FRAMINGHAM, MA 01701

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTIONS 1.12 2022-03-24 deemed execution date A 100,000 (a) 2032-03-24 common stock 100,000 $1.12 100,000 direct
Footnotes
IDfootnote
f1 the shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of march 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on june 24, 2023 and ending on march 24, 2025.
WhaleWisdom Logo

Elevate your investments